Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice

The therapeutic sc"enario of metastatic renal cell cancer (mRCC) has noticeably increased, ranging from the most studied molecular target therapies to those most recently introduced, up to immune checkpoint inhibitors (ICIs). The most recent clinical trials with an ICI-based combination of mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberto, Michela, Botticelli, Andrea, Panebianco, Martina, Aschelter, Anna Maria, Gelibter, Alain, Ciccarese, Chiara, Minelli, Mauro, Nuti, Marianna, Santini, Daniele, Laghi, Andrea, Tomao, Silverio, Marchetti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100507/
https://www.ncbi.nlm.nih.gov/pubmed/33968762
http://dx.doi.org/10.3389/fonc.2021.657639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100507/
https://www.ncbi.nlm.nih.gov/pubmed/33968762
http://dx.doi.org/10.3389/fonc.2021.657639

Ejemplares similares